| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/17/2009 | US7504237 Polynucleotides encoding interferon gamma polypeptides |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2359116C Substituted porphyrins |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2179407C Process for the preparation of leukotriene antagonists |
| 03/12/2009 | WO2009033095A2 Humanized pai-1 antibodies |
| 03/12/2009 | WO2009032887A1 Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol |
| 03/12/2009 | WO2009032764A1 Acetamide stereoisomer |
| 03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009031011A2 Xinafoate salt of n4-(2, 2-difluoro-4h-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-n2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine |
| 03/12/2009 | WO2009030998A1 Pyrimidine compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030929A1 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax |
| 03/12/2009 | WO2009030492A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 03/12/2009 | WO2009030116A1 The use of alkaloids in preparation of medicament for treating cough |
| 03/12/2009 | WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
| 03/12/2009 | WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 03/12/2009 | WO2009011617A3 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 03/12/2009 | WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 03/12/2009 | WO2008116185A3 Substituted pyrimidines as adenosine receptor antagonists |
| 03/12/2009 | WO2008014219A8 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 03/12/2009 | WO2006122806A3 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors |
| 03/12/2009 | US20090069564 Methods and Compositions for Selectin Inhibition |
| 03/12/2009 | US20090069383 Thrombin Receptor Antagonists |
| 03/12/2009 | US20090069382 Bicyclic Angiotensin II Agonists |
| 03/12/2009 | US20090069376 Substituted N [N-(sulphonylphenyl)sulfonyl-prolyl]-phenylalanine derivatives are antagonists of the very late antigen-4 integrin; ulcerative colitis, Crohn's disease, asthma, multiple sclerosis, rheumatoid arthritis |
| 03/12/2009 | US20090069355 Bicyclic pyrazolone cytokine inhibitors |
| 03/12/2009 | US20090069351 Deuterium-enriched bosentan |
| 03/12/2009 | US20090069339 Deuterium-enriched ciprofloxacin |
| 03/12/2009 | US20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069320 Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069276 Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof |
| 03/12/2009 | US20090069236 PROCESS FOR THE PREPARATION OF HYPOALLERGENIC MAJOR BIRCH POLLEN ALLERGEN rBet v 1 |
| 03/12/2009 | US20090068276 Pharmaceutical compositions |
| 03/12/2009 | US20090068274 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | US20090068208 Long term disease modification using immunostimulatory oligonucleotides |
| 03/12/2009 | US20090068196 Pharmaceutical formulation of an antibody against IL13Ralpha1 |
| 03/12/2009 | US20090068195 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 03/12/2009 | US20090068188 C-C chemokine receptor 3 proteins |
| 03/12/2009 | US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/12/2009 | US20090068152 Gene transfer for regulating smooth muscle tone |
| 03/12/2009 | US20090068142 Compositions and methods for treating coronavirus infection and sars |
| 03/12/2009 | US20090068101 A1 Adenosine Receptor Antagonists |
| 03/12/2009 | CA2698683A1 Dheas inhalation compositions |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2698514A1 Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol |
| 03/12/2009 | CA2698396A1 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2698173A1 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2696943A1 Acetamide stereoisomer |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
| 03/11/2009 | EP2033660A1 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 03/11/2009 | EP2033650A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
| 03/11/2009 | EP2032584A2 Thiadiazole compounds and methods of use thereof |
| 03/11/2009 | EP2032555A1 Pyrrole derivatives with crth2 receptor modulator activity |
| 03/11/2009 | EP2032129A2 Compositions of phenylephrine useful for treatment of respiratory illness |
| 03/11/2009 | EP1819710B1 New pyridothienopyrimidine derivatives |
| 03/11/2009 | EP1763368B1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1326586B1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 03/11/2009 | CN101384266A Fixed-dose association of phytate and zinc |
| 03/11/2009 | CN101384258A FGF-peceptor agonist dimeric compounds |
| 03/11/2009 | CN101384254A Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 03/11/2009 | CN101381725A Circular dumbbell decoy oligodeoxynucleotide (CDODN) containing transcription DNA binding sites |
| 03/11/2009 | CN101380468A Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof |
| 03/11/2009 | CN101380460A Preparation method of tea capable of preventing and curing cold |
| 03/11/2009 | CN101380458A Traditional Chinese medicine for treating chronic and urgent cough and asthma and preparation method thereof |
| 03/11/2009 | CN101380436A Traditional Chinese medicine composition for treating chronic pharyngitis |
| 03/11/2009 | CN101380431A Traditional Chinese medicine composition for treating pharyngitis |
| 03/11/2009 | CN101380422A Antioxidation and throat-clearing Dendrobium Moniliforme capsules |
| 03/11/2009 | CN101380411A Traditional Chinese medicine preparation for relieving cough and reducing sputum |
| 03/11/2009 | CN101380410A Medicine for treating hyperactivity of fire due to yin deficiency and preparation method of the formulation thereof |
| 03/11/2009 | CN101380393A Ointment for treating pharyngitis and preparation method thereof |
| 03/11/2009 | CN101380385A Yinqin oral liquid preparation method |
| 03/11/2009 | CN101380376A Wean Qingkailing dispersible tablets |
| 03/11/2009 | CN101380365A Baicao Shenqing traditional Chinese medicine composition and preparation method thereof |
| 03/11/2009 | CN101380328A Medicine for treating coryza and its preparation method |
| 03/11/2009 | CN100467494C Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
| 03/11/2009 | CN100467461C N-oxyde of N-phenyl-2-pyrimidine-amine derivatives |
| 03/11/2009 | CN100467450C Anthranilic acid amides and pharmaceutical use thereof |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives |
| 03/11/2009 | CN100467034C Cough stopping drip pills and its preparation process |
| 03/11/2009 | CN100467030C Trachyostracous mussel extract and its preparation and use |
| 03/11/2009 | CN100467020C Matrix type patch containing bronchodilators |
| 03/11/2009 | CN100467013C Coated magnolia fargesii volatile oil nano liposome nasal drops |
| 03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
| 03/10/2009 | US7501431 Physiologically active substances PF1270A, B and C substances |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |